Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902069 · ClinicalTrials.gov registry record · NA
The Gut-brain Axis in Food Reward and Alcohol Consumption
A NA study of Alcohol Consumption and Impulsivity, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT01902069 is a NA study of Alcohol Consumption and Impulsivity that has completed, run by Yale University. The registered enrollment target is 29 participants, below the 374-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01902069, a NA study of Alcohol Consumption and Impulsivity, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The aims of this project are to: 1. Determine if 3-weeks dietary supplementation with NOPE-EGCG (PhosphoLEANtm, 85mg NOPE+50mg EGCG per capsule) versus a placebo will improve performance on impulsivity, go/no-go tasks and negative outcome learning in heavy drinkers. 2. Evaluate whether supplementation with NOPE-EGCG versus placebo results in reductions in alcohol consumption. 3. Preliminary data in the rodent model suggests that rats treated with OEA shift preference for lower fat test stimuli. In aim 3 we will Determine if 3-weeks of supplementation with PhosphoLEAN shifts fat preference towards lower fat test puddings.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Phospholean
Study Locations (1)
Connecticut
- John B Pierce Laboratory - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01902069
The ClinicalTrials.gov registry entry for NCT01902069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 374-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (92% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Consumption appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01902069 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01902069 about?
NCT01902069 is a clinical study titled "The Gut-brain Axis in Food Reward and Alcohol Consumption". The aims of this project are to: 1. Determine if 3-weeks dietary supplementation with NOPE-EGCG (PhosphoLEANtm, 85mg NOPE+50mg EGCG per capsule) versus a placebo will improve performance on impulsivity, go/no-go tasks and negative outcome learning in heavy drinkers. 2. Evaluate whether supplementat...
What is the current status of trial NCT01902069?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2013-07. Estimated completion is 2014-11.
What conditions does trial NCT01902069 study?
This clinical trial studies the following conditions: Alcohol Consumption, Impulsivity.
What interventions are being tested in trial NCT01902069?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Phospholean (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01902069?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01902069 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Consumption
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial
RECRUITING · NA
-
Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults
RECRUITING · NA
-
Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study
RECRUITING · NA
-
Drinking in Young Adult Duos (DYAD) Study
RECRUITING · NA
-
Engineering an Online STI Prevention Program: RCT
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.